Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate Control
(4-((Neopentyloxy)sulfonyl)phenyl)boronic acid acts as a drug intermediate control with relevance in chemical synthesis. This compound serves as a versatile building block for the production of various pharmaceuticals and research reagents, facilitating the development of novel medicinal compounds. Its unique structural properties contribute to its utility in organic synthesis applications, promoting efficiency in complex molecule assembly. -
Drug Impurity
Mebendazole impurity 5 is a known impurity associated with the anthelmintic agent, Mebendazole. This compound serves as a critical reference standard in the quality control and characterization of pharmaceutical formulations. Its analysis is essential for assessing the purity of Mebendazole, ensuring compliance with regulatory standards in drug formulation and development. -
Drug Impurity
Tetrabenazine impurity 3 is a known impurity associated with Tetrabenazine, a medication used primarily for the treatment of hyperkinetic movement disorders. This compound is critical for analytical purposes in drug development, particularly in ensuring the purity and quality of pharmaceutical formulations. It serves as an important reference for researchers conducting stability studies and investigating the pharmacological effects of Tetrabenazine. -
Drug Intermediate
(S,S)-Reboxetine-OH is a phenolic compound that serves as a vital drug intermediate in pharmaceutical research. Its primary application involves the synthesis of norepinephrine transporter ligands, facilitating investigations into neurotransmitter dynamics and potential therapeutic targets for mood disorders. This compound is instrumental in the development of novel therapeutic agents that modulate norepinephrine levels in the central nervous system. -
Drug Impurity
Rivaroxaban impurity 17 is a chemical impurity associated with the anticoagulant drug Rivaroxaban. This compound is primarily studied in the context of drug quality assessment and formulation development. Its presence may affect the pharmacological profile and safety of Rivaroxaban, making it relevant for analytical research in pharmaceutical sciences. -
Drug Impurity
Everolimus impurity 4 is a chemical impurity associated with the immunosuppressant Everolimus. Its presence is significant for ensuring the analytical quality of pharmaceutical formulations and for conducting impurity profiling in drug development. This compound is utilized in quality control processes and stability studies to assess the purity and efficacy of Everolimus products. -
Drug Impurity
Rifampicin impurity 2, also known as Rifaldazinequinone, is a chemical byproduct associated with the production of Rifampicin. It is primarily investigated in the context of drug quality and safety to assess the stability and efficacy of Rifampicin formulations. Research applications include analytical studies focused on impurity profiling and the evaluation of the pharmacological effects of related compounds. -
Drug Impurity
Palbociclib impurity 48 is a chemical impurity associated with Palbociclib, a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). This impurity is essential for analytical and quality control studies in pharmaceutical development to ensure the purity of Palbociclib formulations. It is particularly relevant in the assessment of drug stability and safety profiles in cancer research applications. -
Drug Impurity
Duloxetine impurity 6, also known as Duloxetine N-desmethyl (R)-isomer, serves as an impurity associated with the pharmaceutical compound Duloxetine. This reagent is primarily utilized in drug development and analysis to assess purity levels and ensure compliance with regulatory standards. Its relevance is critical in studying the pharmacological properties and potential effects of the parent compound in various biological assays. -
Drug Impurity
Azilsartan impurity 23 is a chemical impurity associated with the antihypertensive drug Azilsartan, which targets the angiotensin II receptor. This compound is critical for validation studies and quality control in the pharmaceutical development of Azilsartan formulations. Its presence can influence drug efficacy and safety profiles, making it important for analytical research and regulatory compliance in the development of antihypertensive therapies. -
Drug Impurity
Quetiapine impurity 14 is a drug impurity associated with the antipsychotic agent Quetiapine. It serves as an important reference standard for the analysis and characterization of pharmaceutical formulations containing Quetiapine. This compound can be utilized in quality control processes to ensure the purity and compliance of therapeutic products in research and development settings. -
Drug Impurity
Trazodone impurity 8 hydrochloride is a chemical impurity associated with Trazodone hydrochloride. It serves as a reference standard for studies focused on the identification and quantification of impurities in pharmaceutical formulations. This compound is crucial for ensuring the safety and efficacy of Trazodone products in research applications involving pharmacokinetics and quality control assessments. -
Drug Impurity
Losartan impurity 20, also known as N2-Losartanyl-losartan, serves as a drug impurity related to the antihypertensive agent Losartan. This chemical compound is important for analytical purposes, particularly in the characterization and quantification of drug formulations. Its presence can impact the efficacy and safety profiles of Losartan-based therapies, making it relevant for quality control and stability studies in pharmaceutical research. -
Drug Impurity
Cinakase impurity 1 is a synthetic by-product associated with the production of Cinakase. This compound may impact drug formulation and quality control processes, making it essential for rigorous analytical investigations. Its profile is relevant for studies aiming to assess the stability and purity of pharmacological preparations containing Cinakase. -
Drug Impurity
Trazodone impurity 7 is a chemical impurity associated with trazodone, a serotonin antagonist and reuptake inhibitor. It may serve as a reference standard in analytical studies for the detection and quantification of trazodone impurities in pharmaceutical formulations. This compound is essential for researchers focused on drug purity, stability, and the assessment of trazodone's quality in compliance with regulatory standards. -
Drug Impurity
Tofacitinib impurity 59 is a chemical impurity associated with the JAK inhibitor Tofacitinib. This impurity is relevant for analytical and regulatory research purposes, particularly in the study of drug formulation and stability. It can be employed in quality control processes to ensure the purity and integrity of pharmaceutical products containing Tofacitinib. -
Drug Impurity
Lopinavir impurity 20, also known as Lopinavir impurity Q, is a chemical impurity associated with the antiretroviral drug Lopinavir. It is utilized primarily in drug formulation and quality control studies to ensure the purity and efficacy of pharmaceutical preparations. The characterization of this impurity is essential for compliance with regulatory standards and to support research on the pharmacological profile of Lopinavir. -
Drug Impurity
Nimesulide impurity 7, also known as 4-Nitro-2-phenoxyphenol, is a drug impurity associated with the non-steroidal anti-inflammatory drug Nimesulide. This compound is significant for analytical chemistry applications, particularly in the purity assessment and quality control of pharmaceutical formulations. Understanding this impurity's behavior and effects is essential for regulatory compliance and ensuring the safety and efficacy of Nimesulide-containing products. -
Drug Impurity
Carvedilol impurity 1 is a minor impurity associated with Carvedilol, a non-selective beta-blocker. This compound is utilized primarily in the pharmaceutical industry for quality control and stability testing of Carvedilol formulations. Its analysis is crucial for ensuring the purity and safety of the final drug product in compliance with regulatory standards. Researchers can leverage this impurity in studies focused on drug metabolism and pharmacokinetics. -
Drug Impurity
Estradiol benzoate impurity 1 is a chemical impurity associated with Estradiol benzoate, a synthetic derivative of estrogen. This compound serves as a critical reference for quality control and analytical testing in drug manufacturing processes. Its characterization is essential for ensuring the purity and safety of estradiol-based pharmaceuticals, contributing to compliance with regulatory standards in the pharmaceutical industry. -
Drug Impurity
Citalopram impurity 7 hydrochloride is a drug impurity associated with Citalopram hydrochloride. This compound is utilized in pharmaceutical research to assess the purity and stability of citalopram formulations and to investigate potential effects on drug efficacy and safety profiles. Its analysis is crucial for ensuring the quality of citalopram-based therapies in clinical applications. -
Drug Impurity
Azithromycin impurity 6, also known as Azithromycin C, is a characterized impurity associated with the antibiotic azithromycin. Its presence is significant in drug formulation and quality control contexts, serving as a reference standard for analytical evaluation. This reagent is essential for assessing the purity and stability of azithromycin, aiding in the development of pharmaceutical formulations and compliance with regulatory standards. -
Drug Impurity
Gabapentin acid impurity 7 serves as a chemical impurity of Gabapentin acid. This compound is significant in analytical applications related to drug formulation and quality control, aiding in the assessment of pharmaceutical purity and stability. Researchers utilize this impurity to evaluate the effects of contaminants on drug safety and efficacy, ensuring compliance with regulatory standards. -
Drug Impurity
Pimecrolimus impurity 6 is a characterized impurity of the immunosuppressant Pimecrolimus, targeting the modulation of T-cell activity. This compound is relevant in pharmacological studies assessing drug quality and safety by serving as a benchmark for impurity profiling. Its analysis is critical in the context of pharmaceutical development and regulatory compliance for Pimecrolimus formulations. -
Drug Impurity
Brimonidine impurity 5 is a chemical impurity associated with the synthesis of Brimonidine, which is an alpha-2 adrenergic agonist. This compound is primarily used in drug development to assess the purity and stability of Brimonidine formulations. Understanding and analyzing impurities like Brimonidine impurity 5 is vital for quality control in pharmaceutical research and for ensuring compliance with regulatory standards. -
Drug Impurity
Ramipril impurity 6, also known as Ramipril isopropyl ester, is a known impurity associated with Ramipril synthesis. This compound may be used in pharmaceutical research and development to study its impact on drug stability and efficacy. Its presence in formulations should be monitored to ensure product quality and compliance with regulatory standards. -
Drug Impurity
Methotrexate impurity 1 is a chemical impurity associated with the compound Methotrexate. This impurity may be encountered during the synthesis and purification processes of Methotrexate and serves as a valuable reference for analytical studies. Its presence can impact the efficacy and safety profiles of Methotrexate, making it relevant for quality control assessments and stability testing in pharmaceutical research. -
Drug Impurity
Carvedilol impurity 13 is a known impurity of the beta-blocker carvedilol, which primarily targets beta-adrenergic receptors. This compound is utilized in pharmaceutical research to assess the purity and stability of carvedilol formulations. Its characterization is essential for ensuring compliance with regulatory standards and improving drug quality. -
Drug Impurity
Erythromycin impurity 6 is a known impurity associated with the macrolide antibiotic Erythromycin. This compound is significant for analytical and quality control applications in pharmaceutical development. Researchers utilize Erythromycin impurity 6 for studies related to drug stability, efficacy, and safety, facilitating the understanding of its impact on the pharmaceutical formulation. -
Drug Impurity
Fluticasone impurity 8, also known as Ticabesone propionate, is a drug impurity associated with Fluticasone. This compound is important for quality control and analytical research in pharmaceutical development. It serves as a critical reference for assessing the purity and stability of Fluticasone formulations. -
Drug Impurity
Ranitidine impurity 2 is a known impurity associated with the pharmaceutical compound Ranitidine. This compound is relevant in drug safety assessments and quality control processes, where its presence must be evaluated in the context of Ranitidine formulations. Ranitidine impurity 2 serves as a reference standard for analytical methods aimed at detecting and quantifying impurities in pharmaceutical products. -
Drug Impurity
Lopinavir Impurity 10 is a synthetic impurity associated with the antiretroviral drug Lopinavir. This compound serves as a reference standard for assessing the purity and quality of Lopinavir formulations. Researchers can utilize this impurity in pharmacokinetic studies, stability testing, and in the development of analytical methods for drug identification. -
Drug Impurity
Clarithromycin impurity 12 is a chemically characterized impurity associated with the antibiotic Clarithromycin. This compound is utilized primarily in the analytical evaluation of drug quality and safety, playing a crucial role in pharmaceutical research and development. Analyzing this impurity helps ensure the purity and efficacy of Clarithromycin formulations, thereby supporting regulatory compliance and improving patient outcomes. -
Drug Impurity
Quetiapine impurity 3 is a known impurity associated with the antipsychotic drug Quetiapine. Its characterization is crucial for the analysis of pharmaceutical formulations and quality control processes. This impurity can be used in research to study its potential effects on drug efficacy and safety, providing insights into the overall pharmacological profile of Quetiapine. -
Drug Impurity
Dexmedetomidine impurity 6 (N-Benzyl medetomidine) is a characterized impurity of the sedative and analgesic agent Dexmedetomidine. This compound is used primarily in research settings to study the effects of drug impurities on pharmacological activity and the overall safety profile of Dexmedetomidine formulations. Its presence can impact the efficacy and safety of drug development processes. -
Drug Impurity
Paliperidone impurity 16 is a known impurity of the antipsychotic agent Paliperidone. It is primarily utilized for quality control and characterization in pharmaceutical research and development. This compound serves as a critical reference standard for assessing the purity and stability of pharmaceutical formulations containing Paliperidone, aiding in compliance with regulatory standards. -
Drug Impurity
Levofloxacin impurity 12 is a chemical impurity associated with Levofloxacin, a broad-spectrum antibiotic. This compound may be utilized in analytical studies and quality control processes to assess the purity of Levofloxacin formulations. Understanding such impurities is crucial for regulatory compliance and ensuring the safety and efficacy of pharmaceutical products. -
Drug Impurity
Apixaban impurity 9 is a noted impurity of the anticoagulant apixaban, functioning mainly as a reference standard in pharmacological studies. This compound is utilized in quality control and regulatory settings to ensure the purity of apixaban formulations. Its presence is critical for the assessment of drug stability and efficacy, making it essential for researchers in pharmaceutical development and analytical chemistry. -
Drug Impurity
Mometasone furoate impurity 1 is a chemical impurity associated with Mometasone furoate, a corticosteroid known for its anti-inflammatory properties. The presence of this impurity is relevant in purity assessment and quality control processes for pharmaceuticals. It serves as a crucial reference material in drug development and analytical studies to ensure compliance with regulatory standards. -
Drug Impurity
Tenofovir impurity 3 is a specific impurity associated with Tenofovir, a nucleotide reverse transcriptase inhibitor. This compound is utilized primarily in analytical research to assess the purity and quality of Tenofovir formulations. It serves as a critical reference for the development and validation of analytical methods in pharmaceutical quality control and regulatory compliance. -
Drug Impurity
Salmeterol impurity 3 is a drug impurity associated with the beta-2 adrenergic agonist Salmeterol. It serves as a critical reference standard in analytical chemistry for the identification and quantification of impurities in pharmaceutical formulations. Its presence is important for ensuring the quality and efficacy of Salmeterol-based therapies. This compound can also facilitate investigations into the stability and safety profiles of Salmeterol products. -
Drug Impurity
Rifampicin impurity 4 is a known impurity associated with Rifampicin, an antibiotic used primarily in the treatment of tuberculosis. The identification and quantification of this impurity are crucial for ensuring the quality and safety of pharmaceutical formulations containing Rifampicin. This reagent is valuable for analytical chemistry applications, including purity testing and stability studies, facilitating compliance with regulatory standards in drug development. -
Drug Impurity
Rosuvastatin impurity 15 is a chemical impurity of Rosuvastatin, a competitive inhibitor of HMG-CoA reductase. This impurity is significant for quality control and pharmacokinetic studies in drug development processes. It serves as an essential reference standard for analytical methods assessing the purity of Rosuvastatin formulations in research applications. -
Drug Impurity
Escitalopram impurity 5 is a chemical impurity related to the selective serotonin reuptake inhibitor, escitalopram. This compound is primarily of interest in quality control and assay development for pharmaceutical research, particularly in the analysis and characterization of escitalopram formulations. It serves as a reference standard to evaluate the purity and stability of escitalopram during drug development and regulatory compliance. -
Drug Impurity
Quetiapine impurity 23 is a structural impurity associated with the antipsychotic agent Quetiapine. Its presence can be significant for regulatory compliance and quality control during pharmaceutical development. This compound can be utilized in the assessment of drug purity and characterization studies, ensuring the integrity of Quetiapine formulations in research and clinical applications. -
Drug Impurity
Haloperidol impurity 16, also known as Haloperidol Lauroate, is a byproduct associated with the synthesis of Haloperidol. As a drug impurity, it serves as a valuable reference standard for quality control and analytical studies in pharmacological research. Its structural properties may also provide insights into the metabolic pathways and stability of Haloperidol formulations. This compound is essential for ensuring the purity and efficacy of Haloperidol in clinical and research applications. -
Drug Intermediate
Fluticasone propionate O-diphosphoethanolamine serves as a key drug intermediate in the synthesis of Fluticasone. This compound is utilized in pharmaceutical research and development, particularly in the formulation of corticosteroids for anti-inflammatory therapies. Its biological activity is critical for the synthesis of effective therapeutic agents targeting respiratory diseases. -
Drug Impurity
Clarithromycin impurity 5 (6,11-Di-O-methyl Erythromycin) is a known impurity in the synthesis of Clarithromycin. This compound plays a crucial role in drug quality control and analytical chemistry, enabling the assessment of pharmaceutical purity and efficacy. Its presence is essential for researchers studying the metabolic pathway and stability of macrolide antibiotics. -
Drug Impurity
Allopurinol impurity 6 is a known impurity of allopurinol, which is primarily used for the management of hyperuricemia and gout. This compound serves as a key reference standard in pharmaceutical research and quality control, allowing for accurate analysis of allopurinol formulations. Its characterization is essential for ensuring the purity and compliance of drug products in development and production processes. -
Drug Impurity
Mesalazine impurity 3 is a known impurity of the drug Mesalazine, which primarily targets the inhibition of inflammatory pathways associated with ulcerative colitis. This compound is utilized in quality control and analytical studies to assess the purity of Mesalazine formulations. Its study aids in understanding the degradation products and their potential effects on drug efficacy and safety profiles.
